How effective is the RSV vaccine during pregnancy and how does it work?

Translate to Spanish or other 102 languages!

How safe and effective is the RSV vaccine during pregnancy? Image for illustration purposes
How safe and effective is the RSV vaccine during pregnancy? Image for illustration purposes
- Advertisement -
  • RSV is a respiratory virus affecting about 64 million people around the world each year. 
  • While RSV symptoms may only feel like a common cold to adults and older children, it can be much more serious in older adults, babies, and young children. 
  • About 1.4 million children ages 0 to 6 months are hospitalized from RSV each year.
  • The CDC and American College of Obstetricians and Gynecologists both recommend pregnant people receive an RSV vaccine to help immunize their babies from the disease before they are born. 

Respiratory syncytial virus (RSV) is a respiratory virus causing infection in the lungs, nose, and throat.

Follow the link below to Medical News Today to read the full Story: 

https://www.medicalnewstoday.com/articles/how-safe-effective-is-rsv-vaccine-during-pregnancy

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New AI Tool Accurately Predicts Lung Cancer Immunotherapy Results

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with immunotherapy, according to a new study published in Nature Medicine.

STHS & Prominence Invite Seniors to Free Heart Health & Wellness Conference

Heart disease remains one of the most significant health challenges facing Americans, particularly older adults.

New Study Reveals Coffee’s Protective Perks for Your Liver

A recent study shows higher coffee consumption was associated with lower risks of cirrhosis, liver cancer and liver-related death.

Newly Discovered Genetic Eye Disease Triggers Night Blindness and Tunnel Vision

Scientists identified a new vision condition linked to a gene already connected to a different vision-loss disease. While the previously identified disease causes loss of central vision, the new condition affects peripheral and night vision.
- Advertisement -